Jeffrey Craft

发表

A Bayesian network approach for modeling local failure in lung cancer

Joseph O Deasy, Jeffrey D Bradley, Issam El Naqa, 2011, Physics in medicine and biology.

Investigating Alpha-2-Macroglobulin and Its Dosimetric Interactions for Predicting Radiation Pneumonitis

J. Deasy, J. Bradley, I. Naqa, 2011 .

Quantitative Mass Spectroscopy and the Identification of Alpha2macroglobulin as a Potential Biomarker for Radiation Pneumonitis

J. Deasy, J. Bradley, I. E. Naqa, 2010 .

In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.

S. Achilefu, K. Liang, B. Rogers, 2012, Nuclear medicine and biology.

Cytosolic PhospholipaseA2 Inhibition with PLA-695 Radiosensitizes Tumors in Lung Cancer Animal Models

D. Hallahan, J. Jaboin, D. Thotala, 2013, PloS one.

Neuroinflammation: a potential therapeutic target

L. V. Van Eldik, Jeffrey Craft, D. Watterson, 2005, Expert opinion on therapeutic targets.

Validation of the neuroinflammation cycle as a drug discovery target using integrative chemical biology and lead compound development with an Alzheimer's disease-related mouse model.

L. V. Van Eldik, Jeffrey Craft, Wenhui Hu, 2005, Current Alzheimer research.

Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration

L. V. Van Eldik, Jeffrey Craft, D. Watterson, 2006 .

Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration.

L. V. Van Eldik, Jeffrey Craft, D. Watterson, 2006, Glia.

Mechanism of glial activation by S100B: involvement of the transcription factor NFκB

L. J. Eldik, T. Koppal, A. Lam, 2001, Neurobiology of Aging.

A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics data.

Joseph O Deasy, Jeffrey D Bradley, Issam El Naqa, 2011, Journal of proteome research.

Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against β-amyloid induced injury

L. J. Eldik, J. Haiech, A. Velentza, 2007, Journal of Molecular Neuroscience.

Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against beta-amyloid induced injury: a foundation for future medicinal chemistry efforts focused on targeting Alzheimer's disease progression.

L. V. Van Eldik, J. Haiech, A. Velentza, 2003, Journal of molecular neuroscience : MN.

Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo

S. Frautschy, L. J. Eldik, Jeffrey Craft, 2004, Neurobiology of Aging.

Increased susceptibility of S100B transgenic mice to perinatal hypoxia‐ischemia

L. V. Van Eldik, W. Griffin, Alexander Marks, 2004, Annals of neurology.

Glia as a Therapeutic Target: Selective Suppression of Human Amyloid-β-Induced Upregulation of Brain Proinflammatory Cytokine Production Attenuates Neurodegeneration

L. V. Van Eldik, Ling-yan Guo, Hantamalala Ralay Ranaivo, 2006, The Journal of Neuroscience.

A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

L. V. Van Eldik, Hantamalala Ralay Ranaivo, Jeffrey Craft, 2007, Journal of Neuroinflammation.

Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.

D. Hallahan, Jeffrey Craft, 2011, Future medicinal chemistry.

Enhanced susceptibility of S‐100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β‐amyloid

L. V. Van Eldik, Alexander Marks, Jeffrey Craft, 2005, Glia.

Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human β-amyloid in a murine model of neuroinflammation

L. J. Eldik, L. V. Van Eldik, Jeffrey Craft, 2007, Journal of Molecular Neuroscience.

Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid

L. V. Van Eldik, Jeffrey Craft, D. Watterson, 2005, Journal of Neuroinflammation.

Journal of Neuroinflammation Interleukin 1 Receptor Antagonist Knockout Mice Show Enhanced Microglial Activation and Neuronal Damage Induced by Intracerebroventricular Infusion of Human Β-amyloid

L. V. Van Eldik, J. Van Eldik, Jeffrey Craft, 2005 .

A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

L. J. Eldik, Hantamalala Ralay Ranaivo, Jeffrey Craft, 2007, Journal of Neuroinflammation.

Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid

L. V. Van Eldik, Jeffrey Craft, D. Watterson, 2005, Journal of Neuroinflammation.

A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

L. V. Van Eldik, Jeffrey Craft, Saktimayee M Roy, 2007, Journal of Neuroinflammation.

P4-428 Glia as a therapeutic target: Selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration

L. V. Van Eldik, Ling-yan Guo, Hantamalala Ralay Ranaivo, 2006, Alzheimer's & Dementia.

A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

Hantamalala Ralay Ranaivo, Jeffrey Craft, Saktimayee M Roy, 2007, Journal of Neuroinflammation.